Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Pacific Edge shares (PEB)

What you need to do to buy PEB shares in New Zealand.

Pacific Edge logo

Pacific Edge specialises in developing cancer diagnostic tests to help with the detection and management of cancer. If you’d like to buy Pacific Edge shares (PEB) on New Zealand’s Exchange (NZX), we’ll show you how below.

About our promoted products: Our ‘promoted’ products are presented as a result of a commercial advertising arrangement or to highlight a particular feature. Promoted products are not a recommendation, an indication a product is the best in its category, nor represent all products in the market. It is important to compare your options and find the right product for you.
Some of our promoted products are CFD providers. CFDs are complex financial products and traders are at high risk of losing all of or more than their initial investment

How to buy shares in Pacific Edge on the New Zealand Exchange

  1. Compare share trading platforms. If you’re a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table. Most importantly, you need to find a share trading platform that allows you to trade on the NZX.
  2. Open and fund your share trading account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Pacific Edge. Find the stock by name or ticker symbol: PEB. Research its history to confirm it’s a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Pacific Edge reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimise risk through the market’s ups and downs. You may be able to buy a fractional share of Pacific Edge, depending on your share trading account.
  6. Check in on your investment. Congratulations, you own a part of Pacific Edge. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Compare NZX share trading platforms

Data updated regularly
Name Product Available Investment Types Min. Monthly Fee Currency Conversion Fee Available Markets
Sharesies
Shares, ETFs, Managed Funds, Index Funds
$0
0.4%
ASX, NASDAQ, NYSE, NZX, CBOE
Trade and invest in more than 3,000 companies, ETFs and managed funds across New Zealand, the US and Australia.
ASB Securities
Shares, ETFs, Bonds
$0
1% of value ($10 minimum)
ASX, NZX, and more
Direct Broking
Shares, ETFs, Bonds
$5 per month
Up to 1.50% of transaction value
ASX, NZX
loading

Compare up to 4 providers

Pacific Edge overview and background

Founded in 2001, Pacific Edge is a cancer diagnostics company that specialises in discovering and developing diagnostic and prognostic tests to help detect and manage cancer.

Its current commercial focus is on bladder cancer products, including its Cxbladder cancer detection and management tests, but it has also filed patents for products and tools that target gastric, colorectal and endometrial cancers among others.

The company has laboratories in New Zealand and in the United States, and its headquarters are located in Dunedin.

Performance and company results

In its interim financial statements for the six months to the end of 30 September 2020, Pacific Edge Limited announced the following key results:

  • Operating revenue of $3.3 million (an increase of 46%)
  • Total revenue of $4.1 million (an increase of 50%)
  • Total operating expenses of $11.2 million (a drop of 8%)
  • Total comprehensive loss of $7.1 million (a 25% improvement)

Key details

NamePacific Edge LimitedIndustryDiagnostics & Research
Ticker symbolPEBISINNZPEBE0002S1
TypeOrdinary sharesDate listed on NZX07 Feb 2003
End of financial yearMarchChief executive officerDavid Gregory Darling
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Go to site